The rapid adoption of artificial intelligence (AI) in cardiac CT is major driver of the U.S. and European CCT market. AI technologies are increasingly being integrated into the CCTA workflow to automate image acquisition, reconstruction, coronary segmentation, plaque quantification, stenosis detection, and clinical reporting. These capabilities can improve diagnostic efficiency, reduce interpretation time, and support more consistent assessment of coronary artery disease. A 2025 multisociety scientific statement highlights growing demand for streamlined cardiac imaging workflows and the increasing availability of AI tools for cardiac CT in both Europe and the U.S. AI is also expanding the clinical value of CCTA by enabling automated and quantitative assessment of coronary plaque, potentially supporting personalized cardiovascular risk assessment and treatment decisions.
Access Full Report @ https://www.databridgemarketresearch.com/reports/us-and-europe-cardiac-computed-tomography-cct-market
Data Bridge market research analyzes that The U.S. and Europe Cardiac Computed Tomography (CCT) Market was valued at USD 2.68 billion in 2025 and is projected to reach USD 4.28 billion by 2033, growing at a CAGR of 6.0% from 2026 to 2033.
Key Findings of the Study
Growing Burden of Coronary Artery Disease
The growing burden of coronary artery disease (CAD) is a major driver of the cardiac computed tomography (CCT) market in the U.S. and Europe. CAD remains one of the leading causes of cardiovascular morbidity and mortality, driven by an aging population and the increasing prevalence of risk factors such as obesity, diabetes, hypertension, dyslipidemia, and sedentary lifestyles. As the number of patients presenting with chest pain and suspected coronary disease increases, demand for accurate and timely diagnostic imaging is also rising. CCTA enables non-invasive visualization of coronary arteries, helping clinicians identify stenosis, atherosclerotic plaque, and overall coronary disease burden. In addition, growing awareness of early cardiovascular risk assessment is supporting the use of coronary artery calcium scoring to identify patients at elevated risk. The increasing emphasis on preventive cardiology and early diagnosis is encouraging healthcare providers to adopt advanced imaging modalities that can reduce reliance on invasive diagnostic procedures. Consequently, the expanding CAD patient population is expected to sustain demand for CCT equipment, imaging software, and associated services across developed healthcare markets.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2026 to 2033
|
|
Base Year
|
2025
|
|
Historic Years
|
2018-2024 (Customizable to 2013-2017)
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
By Source (Single Source CT, Dual Source Cardiac CT, Spectral CT), Type (Low Slice, Medium Slice, High Slice), Application (Calcium Scoring, Coronary CT Angiography, Device Implantation, Pulmonary Vein Isolation, Left Atrial Appendage Occlusion, Heart Failure Assessment, Myocardial Infarction / Scar Assessment, Cardiomyopathy Assessment, Others), End User (Hospitals, Speciality Centers, Diagnostic & Imaging Centers, Research and Academic Institutions, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
U.S., Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Sweden, Russia, Belgium, Turkey, Norway, Denmark, Finland, and Rest of Europe
|
|
Market Players Covered
|
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The U.S. and Europe cardiac computed tomography (CCT) market is segmented on the basis of source, type, application, end user, distribution channel, and country.
- On the basis of source, the market is segmented into single source CT, dual source cardiac CT, and spectral CT.
In 2026, the single source CT segment is expected to dominate the market
In 2026, the single source CT segment is expected to dominate the market with a market share of 67.44%, owing to its widespread availability, established clinical use, and cost-effectiveness compared with advanced CT technologies. Single source systems are commonly installed across hospitals and diagnostic centers because they provide reliable cardiac imaging and support routine cardiovascular assessments. Their relatively lower acquisition and maintenance costs, broad compatibility with existing healthcare infrastructure, and suitability for high-volume diagnostic procedures are expected to sustain their leading position during the forecast period.
- On the basis of type, the market is segmented into low slice, medium slice, and high slice systems
In 2026, the low slice segment is expected to dominate the market
In 2026, the low slice segment is expected to dominate the market with a market share of 59.26%, because of its widespread adoption, affordability, and suitability for routine cardiac imaging procedures. Low-slice CT systems offer adequate imaging capabilities for commonly performed cardiovascular examinations while requiring comparatively lower capital investment than medium- and high-slice systems. Their availability across hospitals, diagnostic centers, and other healthcare facilities, combined with established operating workflows and easier maintenance, is expected to support continued demand throughout the forecast period.
- On the basis of application, the market is segmented into calcium scoring, coronary CT angiography, device implantation, pulmonary vein isolation, left atrial appendage occlusion, heart failure assessment, myocardial infarction/scar assessment, cardiomyopathy assessment, and others.
In 2026, the calcium scoring segment is expected to dominate the market
In 2026, the calcium scoring segment is expected to dominate the market with a market share of 31.75%, because of the growing use of coronary artery calcium assessment for evaluating cardiovascular risk. Calcium scoring is a relatively rapid, non-invasive, and cost-effective examination that can help identify individuals at increased risk of coronary artery disease. Increasing awareness of preventive cardiovascular care, rising prevalence of cardiovascular disorders, and growing adoption of early risk assessment are expected to drive demand for calcium scoring applications across healthcare settings during the forecast period.
- On the basis of end user, the market is segmented into hospitals, specialty centers, diagnostic & imaging centers, research and academic institutions, and others.
In 2026, the hospitals segment is expected to dominate the market
In 2026, the hospitals segment is expected to dominate the market with a market share of 44.77%, owing to their extensive patient volumes, advanced diagnostic infrastructure, and availability of specialized cardiovascular services. Hospitals increasingly utilize cardiac CT for diagnosis, treatment planning, and follow-up of various cardiovascular conditions. The presence of multidisciplinary cardiac teams, established imaging departments, and greater access to advanced medical technologies further supports adoption. Additionally, increasing cardiovascular disease burden and growing demand for comprehensive diagnostic services are expected to strengthen the segment's market position.
- On the basis of distribution channel, the market is segmented into direct tender and retail sales
In 2026, the direct tender segment is anticipated to dominate the market
In 2026, the direct tender segment is expected to dominate the market with a market share of 84.47%, due to the significant role of institutional procurement in acquiring high-value medical imaging equipment. Hospitals and healthcare organizations frequently purchase CT systems through formal tendering processes, enabling them to evaluate suppliers based on technology, pricing, service agreements, and technical specifications. Direct tender procurement also facilitates large-scale equipment purchases and standardized purchasing procedures. Increasing investments in hospital infrastructure, diagnostic imaging capacity, and healthcare modernization are expected to support the segment's dominance.
Major Players
SIEMENS HEALTHCARE GMBH (Germany), GE HEALTHCARE (U.S.), KONINKLIJKE PHILIPS N.V. (Netherlands), CANON MEDICAL SYSTEMS CORPORATION (Japan), and FUJIFILM CORPORATION (Japan).
Market Developments
- In December 2025, Siemens Healthineers launched Syngo.CT Coronary Cockpit at RSNA 2025, an AI-powered software application within the Syngo.via imaging platform. The tool automatically segments coronary arteries, characterizes plaque morphology, and delivers pre-procedural 3D mapping to aid interventional cardiologists during percutaneous coronary intervention (PCI) planning.
- In September 2025, Varian, a Siemens Healthineers company, introduced major technological upgrades for its Halcyon radiation therapy platform at ASTRO 2025. The enhanced system integrates real-time motion management, high-resolution cone-beam CT imaging, and automated patient positioning tools designed to maximize targeted radiation dose accuracy while lowering overall energy consumption.
- In August 2026, GE HealthCare expanded its ultrasound portfolio with the introduction of the new LOGIQ e family platform. The updated system features enhanced high-definition image processing, cloud-connected workflow tools, and specialized probe configurations designed to streamline point-of-care, musculoskeletal, and general diagnostic imaging applications.
- In October, Philips introduced an industry-first cath lab integration that connects pre-operative CT data with the Azurion image-guided therapy platform. The new Follow C-arm capability within Philips Advanced Visualization Workspace automatically synchronizes the 3D reconstruction of coronary arteries with the movement of the Azurion C-arm, allowing the CT volume to rotate in real time with the C-arm angulation. The integration is designed to provide interventional cardiologists with additional 3D anatomical information during complex PCI procedures and represents a step toward CT-guided PCI.
- In July 2026, Canon Medical Systems USA introduced advanced AI-powered CT technologies featuring updated Deep Learning Reconstruction models. The platform is engineered to deliver high spatial and temporal resolution while maintaining low radiation doses and automated scanner workflows for high-volume imaging centers.
As per Data Bridge Market Research analysis:
Geographically, the countries covered in the U.S. and Europe cardiac computed tomography (CCT) market report are U.S., Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Russia, Turkey, Norway, Belgium, Sweden, Denmark, Finland, and Rest of Europe.
U.S. Cardiac Computed Tomography (CCT) Market Insight
The U.S. CCT market is driven by advanced healthcare infrastructure, high adoption of non-invasive cardiac imaging, increasing demand for coronary CT angiography (CCTA), and growing emphasis on early cardiovascular disease detection. Favorable reimbursement, established cardiac imaging centers, and widespread availability of CT systems support market penetration. In addition, rapid adoption of high-resolution scanners, AI-enabled image analysis, automated plaque assessment, and calcium scoring is improving diagnostic efficiency. The increasing integration of CCT into routine coronary disease assessment and preventive cardiology is further supporting market expansion.
Germany is the dominating country in Europe cardiac computed tomography (CCT) market
Germany dominates the European CCT market, supported by well-established healthcare infrastructure, high healthcare expenditure, and strong adoption of advanced medical imaging technologies. Growing demand for non-invasive coronary assessment is encouraging hospitals and specialized cardiac centers to expand CCTA and calcium-scoring capabilities. Increasing investment in high-resolution and AI-assisted CT systems is further supporting technology adoption. Integration of cardiac CT with hospital information systems and digital imaging platforms improves workflow efficiency. In addition, greater emphasis on early cardiovascular disease detection and preventive cardiology is strengthening demand for advanced cardiac imaging technologies across Germany.
U.K. Cardiac Computed Tomography (CCT) Market Insight
The U.K. CCT market is supported by growing adoption of CCTA, increasing emphasis on early coronary artery disease detection, and established national healthcare infrastructure. Clinical guidelines supporting CCTA as an important diagnostic pathway are encouraging broader utilization. Rising investment in advanced CT equipment, particularly in hospitals and specialist cardiac centers, is improving access to cardiac imaging. Increasing adoption of AI-assisted coronary analysis and automated reporting is also enhancing workflow efficiency. Furthermore, pressure to improve diagnostic capacity and reduce waiting times is encouraging healthcare providers to expand non-invasive cardiac imaging services and upgrade existing CT infrastructure.
For more detailed information about the U.S. and Europe cardiac computed tomography (CCT) market report, click here – https://www.databridgemarketresearch.com/reports/us-and-europe-cardiac-computed-tomography-cct-market
